HIGHFDA DRUG

Cipla USA Recalls Lanthanum Carbonate Tablets Over Stability Issues

Cipla USA recalled 1,180 boxes of Lanthanum Carbonate chewable tablets on October 24, 2025. The recall follows a failure to meet stability specifications for hardness tests. Consumers and healthcare providers must stop using the product immediately.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
October 24, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
October 24, 2025
Hazard Level
HIGH
Brands
LANTHANUM CARBONATE, Cipla USA Inc.
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
LANTHANUM CARBONATE, Cipla USA Inc.
Product type
Lanthanum Carbonate Chewable Tablets
Model numbers
lot# NB240315, exp 12/31/2025
UPC codes
69097-934, 69097-935, 69097-936, 69097-934-57, 69097-934-98, 69097-935-89, 69097-935-98, 69097-936-65 +1 more
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    October 24, 2025

  2. Reported by FDA DRUG

    December 17, 2025

  3. RecallRadar source check

    April 13, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Failed stability specifications: Out of specification for hardness test

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Cipla USA, Inc. or your healthcare provider for guidance. Notification method: N/A

About This Product

Lanthanum Carbonate chewable tablets are prescribed to manage phosphate levels in patients with kidney disease. They help reduce the risk of complications associated with high phosphate levels.

Why This Is Dangerous

The recalled tablets did not meet stability specifications for hardness, which could impact their effectiveness as a treatment.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers should be aware that using ineffective medication could lead to health complications, necessitating immediate action.

Practical Guidance

How to identify if yours is affected

  1. Check the lot number on the product: NB240315.
  2. Verify the expiration date: 12/31/2025.
  3. If you have the product, stop using it immediately.

Where to find product info

The lot number and expiration date can typically be found on the bottom or side of the bottle.

What timeline to expect

Expect a refund or replacement processing time of 4-6 weeks after return.

If the manufacturer is unresponsive

  • Follow up with Cipla USA, Inc. via phone or email.
  • Document all communications for your records.

How to prevent similar issues

  • Always check for recalls before using medications.
  • Look for stability testing results in product information.

Documentation advice

Keep receipts and any correspondence with the manufacturer regarding the recall.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recall includes Lanthanum Carbonate chewable tablets, 1000mg. The affected lot number is NB240315, with an expiration date of December 31, 2025. The product was distributed nationwide in the USA.

Key Facts

  • Recall date: October 24, 2025
  • Quantity recalled: 1,180 boxes
  • Lot number: NB240315

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
lot# NB240315
exp 12/31/2025
UPC Codes
69097-934
69097-935
69097-936
+6 more
Affected States
ALL
Report Date
December 17, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls